Name: UMIN ID:
Unique ID issued by UMIN | C000000113 |
---|---|
Receipt number | R000000166 |
Scientific Title | phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive disease small-cell lung cancer. |
Date of disclosure of the study information | 2005/09/05 |
Last modified on | 2016/09/27 16:30:54 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/09/05 15:33:57 | ||
2 | Update | 2005/09/08 17:22:56 | Public title Public title Acronym Acronym |
|
3 | Update | 2008/05/26 17:02:29 | Recruitment status |
|
4 | Update | 2008/05/26 17:16:55 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Name of person sending information Organization Division name Address TEL Institute Institute Organization Organization Category of Funding Organization Organization1 Address1 Tel1 Email1 |
|
5 | Update | 2008/05/26 17:17:11 | Last follow-up date |
|
6 | Update | 2015/04/06 09:53:21 | Recruitment status |
|
7 | Update | 2015/04/06 10:00:05 | Publication of results |
|
8 | Update | 2015/08/31 15:43:29 | URL related to results and publications |
|
9 | Update | 2016/09/27 16:30:54 | Recruitment status |